Acurx Pharmaceuticals (ACXP) Misses Q3 EPS by 2c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q3 EPS of ($0.17), $0.02 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00
• Raymond James on Dianthus Therapeutics (DNTH) Amid 8% Gain: 'Incrementally More Bullish On The CIDP Program (again)'